lung cancer society
Leading experts to discuss latest pharmacogenomic research at European Lung Cancer Conference
Rapid advances in drug development, genetics and multidisciplinary treatment have brought the field of oncology to a critical moment, says Dr. Rafael Rosell from the Catalan Institute of Oncology in Badalona, Spain, co-chair of the second European Lung Cancer Conference (ELCC), which will be held in Geneva, Switzerland from 28 April to 1 May 2010.
Poly MVA: Cancer Control Convention 2003 – Part 1
